Obuli Ramachandran Nandhakumar

Vanakkam.

Dr Obuli Ramachandran Nandhakumar · Vitreoretinal Surgeon, Delhi NCR

I operate on retinas, and on the economics of the hospitals around them.

I am a retina specialist and vitreoretinal surgeon at Centre for Sight in New Delhi and Gurugram. I work on health economics, healthcare strategy and AI in healthcare, and I advise hospitals, startups and investors as co-founder of Aavinyaa Strategies, a healthcare venture studio incubated at AIC NIFIE, IIM Mumbai.

I treat diseases of the retina, with surgery, injections and laser.

I am a retina specialist and vitreoretinal surgeon at Centre for Sight in New Delhi and Gurugram. I have performed more than 5,000 retina surgeries and 10,000 injections and laser procedures. This page tells you what I treat and how to book an appointment.

I read eye hospitals from the theatre and from the balance sheet.

I am a practising vitreoretinal surgeon and co-founder of Aavinyaa Strategies. I advise hospitals and investors on operations, due diligence and sector research, and I wrote a report on five years of accounts of India's eye hospital chains.

I help healthcare startups get from idea to clinic.

Through Aavinyaa Strategies I have evaluated more than 100 healthcare ventures. I advise founders on clinical validation, the CDSCO regulatory pathway, financial models and access to hospitals. I also evaluate AI products as a practising surgeon.

Gurugram time

5,000+

vitreoretinal surgeries performed

10,000+

intravitreal and laser procedures performed

30+

peer-reviewed publications across PubMed, EMBASE and Cochrane

100+

healthcare ventures evaluated through Aavinyaa Strategies

12

eye care businesses analysed from five years of audited accounts

4

cities where I helped build retina services

2

randomised trials co-authored

About

About Me

How I Came to Management

I was born in Salem, Tamil Nadu. My family are weavers from Singalandapuram, a small village near Rasipuram, and both my parents come from small villages. My father was the second graduate in our family and worked as a bank manager. His job came with frequent transfers, so I grew up across the country and studied in more than seven schools.

I studied medicine at Kilpauk Medical College, Chennai. Ophthalmology was not my first choice. I chose it because I had the chance to train at the Dr Rajendra Prasad Centre for Ophthalmic Sciences at AIIMS New Delhi, the apex institute of our country. My love for the retina started there. My senior residents kept us back until midnight, made us examine the retina with the indirect ophthalmoscope and taught us the findings. Those nights left an imprint on me.

I joined Aravind Eye Hospital, Madurai, in 2017 for my vitreoretinal fellowship and stayed on as a consultant until 2021. I now work at Centre for Sight in Delhi NCR. I have performed more than 5,000 vitreoretinal surgeries and 10,000 intravitreal injections and laser procedures.

My interest in management started at Aravind. I attended the monthly reviews and quality control meetings, worked in LAICO outreach camps, and did capstone projects with visiting MBA students from the United States. My head of department, Dr Naresh Babu, has an MBA, and that made me want to study management.

I completed the Advanced Management Programme in Healthcare at the Indian School of Business and was on the Dean's List. I then completed the FMVA certification in financial modelling and valuation. I co-founded Aavinyaa Strategies, a healthcare venture studio incubated at AIC NIFIE, IIM Mumbai.

I divide my week between surgery at Centre for Sight and my work at Aavinyaa Strategies. I write about healthcare economics for ophthalmologists because I want more doctors to understand financial statements.

Family

My wife, Dr Gauri Khare, is a vitreoretinal surgeon at Centre for Sight and a co-author on several of my papers. We live in Gurugram with our young daughter.

Outside Work

I collect automatic watches. I have suffered as a supporter of ever since Alex Ferguson left. I also follow the Los Angeles Lakers and CSK. I read history and listen to a curated list of podcasts.

See some of the watches in my collection

Dr Obuli Ramachandran: With Gauri and our daughter at the Indian School of Business
With Gauri and our daughter at the Indian School of Business
Surgeon and venture builder

Why I Do Both

I am a practising vitreoretinal surgeon. I have performed more than 5,000 retina surgeries, trained fellows, examined for national boards and published more than 30 papers.

I give part of my week to Aavinyaa Strategies, a doctor-led healthcare venture studio, because I want hospitals and healthcare startups to deliver better care to more patients. I work with hospital owners on how their centres run, and with founders on proving that their products work in a real clinic.

Career

Work and Achievements

My training and work at AIIMS, Aravind Eye Hospital, Centre for Sight and Aavinyaa Strategies.

Chapter One

AIIMS

Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS New Delhi. MD Ophthalmology, 2013 to 2016.

  • Performed more than 100 phacoemulsification surgeries as a resident
  • Independently managed the trauma theatre and the eye casualty
  • Performed lid surgery, dacryocystorhinostomy, trabeculectomy and corneal transplants
  • Performed vitrectomies for endophthalmitis
  • Thesis on oral steroids in paediatric orbital cellulitis, with a comparison of treatment response in adults. We found meaningful improvement when steroids were started together with intravenous antibiotics
Dr Obuli Ramachandran: With my MD degree at the 45th AIIMS convocation, January 2018
With my MD degree at the 45th AIIMS convocation, January 2018
Chapter Two

Aravind

Aravind Eye Hospital, Madurai. Vitreoretinal Fellow, 2017 to 2019. Consultant, 2019 to 2021.

  • About 2,500 vitreoretinal surgeries in two and a half years, and more than 6,000 intravitreal injections and laser procedures
  • Vitreoretinal fellowship (FVRS) under Dr Naresh Babu
  • Surgery for retinal detachment, including cases with proliferative vitreoretinopathy, choroidal detachment and coloboma
  • Macular hole surgery, diabetic vitrectomy, scleral-fixated intraocular lenses, ocular trauma and 3-D heads-up surgery
  • As a consultant, headed my own operating day
  • Conducted masterclasses on scleral-fixated IOLs and diabetic vitrectomy
  • Presented at journal clubs and took classes for postgraduate residents
  • Co-author of two randomised trials: platelet-rich plasma against the inverted ILM flap for large macular holes, and intravitreal methotrexate in proliferative vitreoretinopathy
  • Worked with Google Research on AI screening for diabetic retinopathy
  • Outreach camps with LAICO, quality control meetings, and capstone projects with visiting MBA students from the United States
Dr Obuli Ramachandran: With Dr Naresh Babu
With Dr Naresh Babu
Dr Obuli Ramachandran: Surgical training in the operating theatre at Aravind
Surgical training in the operating theatre at Aravind
Dr Obuli Ramachandran: Outreach camp visit, Rameswaram
Outreach camp visit, Rameswaram
Chapter Three

Centre for Sight

Centre for Sight Eye Institute, Delhi NCR. Associate Consultant, 2021 to 2024. Consultant Vitreoretinal Surgeon and Fellowship Co-Incharge, 2024 to present.

  • More than 2,500 vitreoretinal surgeries and 4,000 intravitreal injections and laser procedures
  • Eyeconic 2025 award for the highest number of vitreoretinal surgeries in the organisation in FY 2024 to 25
  • Helped build retina services in Agra, Hisar, Gurugram and Ranchi, and raised surgical capacity at Gurugram and Safdarjung Enclave
  • Surgical trainer for vitreoretinal fellows and Fellowship Co-Incharge
  • External examiner, invited by the National Board of Examinations, for the FNB Vitreoretina exit examination
  • Examiner for the FAICO examination of the All India Ophthalmological Society
  • Started and led process improvement and optimisation projects across the organisation
  • Led the organisation's evaluation of multiple AI products for ophthalmology
  • Site investigator for an aflibercept biosimilar clinical trial
Dr Obuli Ramachandran: Centre for Sight
Centre for Sight
Dr Obuli Ramachandran: With senior colleagues at Centre for Sight
With senior colleagues at Centre for Sight
Dr Obuli Ramachandran: With the team at Centre for Sight
With the team at Centre for Sight
Chapter Four

Aavinyaa Strategies

Aavinyaa Strategies, a doctor-led healthcare venture studio, 2025 to present. Co-founder and VP, Strategy and Operations. I co-founded it with colleagues from the ISB Advanced Management Programme in Healthcare, and I do this work alongside my surgical practice at Centre for Sight.

  • Startups. I have evaluated more than 100 healthcare ventures. I advise founders on clinical validation, the CDSCO regulatory pathway, investor-ready financial models and market access through partner hospitals
  • Clinics, diagnostics and hospitals. I work with owners on throughput, ARPOB, occupancy, revenue cycle and denial reduction, and on site feasibility and expansion models for multi-location growth
  • Investors. I carry out clinical and operational due diligence for venture capital, private equity and angel investors, and I write sector and equity research on Indian healthcare
  • Incubators and CSR funders. I screen cohorts and mentor founders for incubators, and I help CSR funders design and verify healthcare projects
  • The All India Ophthalmological Society invited Aavinyaa Strategies to be its innovation partner
  • Expert network. Network Member at GLG since June 2026, covering healthcare, ophthalmology and AI in healthcare
  • Aavinyaa Strategies operates as Moonshot Advisory Private Limited and is incubated at AIC NIFIE, IIM Mumbai
  • Advanced Management Programme in Healthcare, Indian School of Business, Dean's List
  • Financial Modelling and Valuation Analyst, Corporate Finance Institute
Dr Obuli Ramachandran: Aavinyaa Strategies, innovation partner of the All India Ophthalmological Society, at AIOC 2026, Jaipur
Aavinyaa Strategies, innovation partner of the All India Ophthalmological Society. AIOC 2026, Jaipur
Dr Obuli Ramachandran: ISB graduation, 2025
ISB graduation, 2025
Expertise

Areas of Expertise

What I Treat

Work With Hospitals and Investors

Work With Startups

My work covers four areas: retina surgery, health economics in ophthalmology, healthcare strategy, and AI in healthcare.

Retina and Vitreoretinal Surgery

I am a retina specialist and vitreoretinal surgeon in Delhi NCR. I operate at Centre for Sight hospitals in New Delhi and Gurugram and treat medical and surgical diseases of the retina.

Conditions I treat

Retinal detachmentDiabetic retinopathyDiabetic macular oedemaMacular holeEpiretinal membraneVitreous haemorrhageAge-related macular degenerationRetinal vein occlusionCentral serous chorioretinopathyProliferative vitreoretinopathyEndophthalmitisEye injuries involving the retina

Procedures I perform

Pars plana vitrectomyRetinal detachment surgeryScleral bucklingMacular hole surgery with ILM peelingDiabetic vitrectomyAnti-VEGF injectionsOzurdex implantRetinal laserScleral-fixated and glued IOL

Health Economics in Ophthalmology

I study what eye treatments cost in India and what patients gain from them. I use cost-utility analysis, real-world evidence and systematic reviews.

Research subjects

Cost-effectiveness of anti-VEGF therapyAflibercept, ranibizumab and biosimilarsTreatment burden in diabetic macular oedemaValue-based care in eye hospitalsAI screening for diabetic retinopathyValidation of indigenous medical devices

Methods

Cost-utility analysisHealth economics and outcomes researchReal-world evidenceSystematic review and meta-analysisRandomised controlled trials

Healthcare Consulting and Strategy

Through Aavinyaa Strategies I advise eye hospitals, healthcare startups and investors in India. I combine surgical practice with training in management and finance.

Work for hospitals and clinics

Eye hospital operationsRetina service set-upHub and spoke network designRevenue cycle and denial reductionSite feasibility and expansionFinancial literacy for doctors

Work for startups and investors

Clinical validationEvaluation of clinical AI productsCDSCO regulatory pathwayClinical and operational due diligenceSector and equity researchIndian eye care market analysisFinancial modelling and valuation

AI in Healthcare

I have worked with clinical AI in three roles: as a researcher, as the person who evaluates AI products for a hospital group, and as an adviser to startups and investors. I help hospitals and practices decide which AI tools to adopt and how to bring them into daily clinical work.

My experience

  • Worked with Google Research on AI screening for diabetic retinopathy during my fellowship at Aravind Eye Hospital, 2017 to 2019
  • Led Centre for Sight's evaluation of multiple AI products for ophthalmology
  • Advise healthcare startups on clinical validation and the CDSCO regulatory pathway through Aavinyaa Strategies
  • Panelist on AI in healthcare in 2026, representing Centre for Sight

Implementation work

Selection and evaluation of AI productsClinical validation and review of evidenceFitting AI into clinic and operating theatre workflowRegulatory pathway for AI as a medical deviceCost and return on AI toolsTraining and adoption by doctors and staffHuman oversight of AI in patient care
Recognition

Awards, Examiner Roles and Degrees

Awards and Recognition

2023

Asia's Best Surgical Video, APVRS

Awarded at the Asia-Pacific Vitreo-retina Society congress in Hong Kong.

2025 and 2026

Best Video Award, SFO Session, AIOS

Won in two consecutive years at the annual conference of the All India Ophthalmological Society.

Dr Obuli Ramachandran: With the trophy at the AIOS annual conference
With the trophy at the AIOS annual conference
Multiple years

Best Video Award, Ophthalmic Premier League

Won more than once at the Ophthalmic Premier League of the All India Ophthalmological Society.

Dr Obuli Ramachandran: Eyeconic 2025 certificate
Eyeconic 2025 certificate
2025

Eyeconic Award, Centre for Sight

For the highest number of vitreoretinal surgeries in the organisation in FY 2024 to 25, and for building retina services across several centres.

Dr Obuli Ramachandran: ISB graduation, 2025
ISB graduation, 2025
ISB

Dean's List, Indian School of Business

Advanced Management Programme in Healthcare. Awarded to the top five of the cohort.

2020

Best Poster in Vitreo Retina, TNOA

Tamil Nadu Ophthalmic Association annual conference.

Examiner and Reviewer Roles

Review
Peer ReviewerReviewer for national and international journals. I have reviewed more than 30 papers for publication.
NBE
External Examiner, FNB VitreoretinaInvited by the National Board of Examinations for the fellowship exit examination.
AIOS
Examiner, FAICOExaminer for the Fellowship of the All India Collegium of Ophthalmology.
Training
Surgical TrainerTrainer for vitreoretinal fellows and Fellowship Co-Incharge at Centre for Sight.
Dr Obuli Ramachandran: Examining at the FAICO examination
Examining at the FAICO examination

Degrees and Fellowships

6/60MD
6/36MRCS (Ed)
6/24FVRS · FAICO · FICO
6/12AMPH · FMVA
6/9AIIMS · Aravind · Royal College of Surgeons of Edinburgh · ISB · CFI
6/6If you can read this line, your macula is doing its job.
Clinic and research

OCT and Cost-Effectiveness Analysis

I use two kinds of chart in my work. In clinic I read OCT scans of the macula. In research I use cost-effectiveness analysis to compare treatments.

250 ┬╡m
Plate I. The macula on optical coherence tomographyMove the cursor across the scan to measure retinal thickness. This is a drawing made in code and is not a patient scan.
Health economics

The Cost-Effectiveness Plane

Each point is one simulated comparison of a new treatment with the current standard. Points further right add more health. Points higher up cost more. The dashed line is the most a payer will spend for one year of good health. A treatment is cost-effective when most of the points fall below that line.

I am building this analysis for the treatments of diabetic macular oedema in India.

Plate II. The cost-effectiveness planeIllustration with simulated points.
Research

Papers, Essays and Presentations

Sector report 2026-27

Five Years of Financials of India's Major Eye Care Chains and Hospitals

I studied the audited accounts of twelve eye care businesses from FY22 to FY26. The report has its own page with an interactive timeline and charts.

Open the sector report

Most Cited Papers

21Citations

Comparison of platelet-rich plasma and inverted internal limiting membrane flap for the management of large macular holes: a pilot study

Babu N, Kohli P, Ramachandran NO, Adenuga OO, Ahuja A, Ramasamy K. Indian J Ophthalmol. 2020;68(5):880-884. doi:10.4103/ijo.IJO_1357_19

8Citations

Comparison of surgical performance of internal limiting membrane peeling using a 3-D visualization system with conventional microscope

Babu N, Kohli P, Ramachandran NO, Ramasamy K. Ophthalmic Surg Lasers Imaging Retina. 2018;49(12):941-945.

6Citations

Intravitreal methotrexate as an adjuvant in vitrectomy in cases of retinal detachment with proliferative vitreoretinopathy

Rajan RP, Babu KN, Arumugam KK, Muraleedharan S, Ramachandran O, et al. Graefes Arch Clin Exp Ophthalmol. 2025;263(2):387-391. doi:10.1007/s00417-024-06665-w

6Citations

Rare cause of floaters: a motile live worm in vitreous cavity

Rajan RP, Jena S, Ramachandran NO, Kohli P. Indian J Ophthalmol. 2019;67(9):1490-1492. doi:10.4103/ijo.IJO_79_19

5Citations

Abnormal retinal vasculature in a young child: a diagnostic dilemma

Kannan NB, Kohli P, Ramachandran NO. Ocul Immunol Inflamm. 2021;29(1):175-178.

Citation counts from Crossref, October 2026. Full list on ORCID 0000-0001-8498-9538 and Google Scholar.

Published in 2026

2026
Real-world efficacy of higher-dose aflibercept in pro-re-nata dosing without loading phasesFirst author. Indian J Ophthalmol. 74(11):1714-1719. 194 eyes, 22.6% fewer annual visits, 8.52 hours saved per patient per year. DOI
2026
Long-term analysis of intravitreal brolucizumab in chronic central serous retinopathy with neovascularizationIndian J Ophthalmol. 74(6):893-900. DOI
2026
Peep into anti-vascular endothelial growth factorReview. Indian J Ophthalmol. 74(5):635-638. DOI
Now
Work in progressCost-utility analysis of treatments for diabetic macular oedema in India. PROSPERO-registered systematic review of endophthalmitis after cataract surgery.

Essays and Sector Writing

2026
The Retina GapEssay on the distance between the retina care India needs and the care it delivers, built from public filings and Aravind's activity reports since 2000.
2026
The Retina DriftEssay drawn from interviews with 23 retina surgeons on how their practices have changed.
2026
NMC Advertising Guidelines 2026, in Four PartsSeries on what the guidelines of 6 October 2026 mean for doctors, hospitals and the investors who fund them.

I publish these on LinkedIn.

Publications

2026
Real-world efficacy of higher-dose aflibercept in pro-re-nata dosing without loading phases: A cost-effective approach for resource-limited settingsIndian J Ophthalmol. DOI
2026
Long-term analysis of intravitreal brolucizumab in recalcitrant cases of chronic central serous retinopathy complicated by neovascularization (pachychoroid neovasculopathy)Indian J Ophthalmol. DOI
2026
Peep into anti-vascular endothelial growth factorIndian J Ophthalmol. DOI
2026
Historical trends in vitreoretinal care: The evolving landscape in North IndiaIndian J Ophthalmol. DOI
2025
Intravitreal methotrexate as an adjuvant in vitrectomy in cases of retinal detachment with proliferative vitreoretinopathyGraefes Arch Clin Exp Ophthalmol. DOI
2024
Short-term postoperative perfluorocarbon liquid-silicone oil combination tamponade for chronic rhegmatogenous retinal detachment: Initial experienceIndian J Ophthalmol. DOI
2022
Frosted branch angiitis following corneal tear repairTaiwan J Ophthalmol. DOI
2021
Two-staged surgery as an alternative to buckle-vitrectomy for rhegmatogenous retinal detachment complicated by choroidal detachmentInt Ophthalmol. DOI
2021
Abnormal retinal vasculature in a young child: a diagnostic dilemmaOcul Immunol Inflamm.
2020
Comparison of platelet-rich plasma and inverted internal limiting membrane flap for the management of large macular holes: A pilot studyIndian J Ophthalmol. DOI
2020
Multimodal imaging-guided diagnosis, management and follow-up of a case of diffuse unilateral subacute neuroretinitisBMJ Case Rep. DOI
2020
Comment on: Clinical presentations and comparative outcomes of primary versus deferred intraocular lens explantation in delayed.onset endophthalmitisIndian J Ophthalmol. DOI
2020
Management of coexistent choroidal neovascular membrane and macular hole with serous detachment in a case of pathological myopia: challenges and dilemmasBMJ Case Rep. DOI
2020
Clinical Spectrum and Long-Term Anatomical and Functional Outcomes of Pars Plana Vitrectomy in Retinal Detachments Associated With Choroidal ColobomaJ Vitreoretin Dis. DOI
2019
Rare cause of floaters: A motile live worm in vitreous cavityIndian J Ophthalmol. DOI
2018
Comparison of surgical performance of internal limiting membrane peeling using a 3-D visualization system with conventional microscopeOphthalmic Surg Lasers Imaging Retina.

The complete list is on ORCID and Google Scholar.

Presentations

2026
ASRS Annual MeetingExpert panel presentation at the American Society of Retina Specialists: "Platform Matters? Comparative Effectiveness of 5 Vitrectomy Systems in 1,082 Primary Vitreoretinal Surgeries".
2026
ARVO Annual MeetingPoster on the pooled prevalence of dry eye disease, 31.8%. Abstract 446317.
2026
Saudi Retina Symposium, JeddahInvited presentation.
2025
MEOM, DubaiInvited speaker.
2021 to 2026
All India Ophthalmological Society Annual ConferenceInvited speaker in 2021, 2022, 2024, 2025 and 2026. In 2026 I spoke on the glued IOL in the instruction course on scleral-fixated lenses.
2022 to 2025
EURETINASurgical videos invited in 2022, 2023 and 2025.
2023
APVRS, Hong KongSurgical video presentation. Won Asia's Best Surgical Video.
Ongoing
Invited Industry TalksSpeaker for Novartis, AbbVie, Sun Pharma and Reliance Life Sciences on my experience with anti-VEGF therapy and Ozurdex.
2026
Panel on AI in HealthcarePanelist representing Centre for Sight.
2026
Aravind Golden Jubilee Reunion Meet, MaduraiAlumni talk, December.
Questions

Frequently Asked Questions

Who is Dr Obuli Ramachandran?

I am Dr Obuli Ramachandran Nandhakumar, a consultant vitreoretinal surgeon at Centre for Sight in Delhi NCR. I trained at AIIMS New Delhi and Aravind Eye Hospital, Madurai. I have performed more than 5,000 vitreoretinal surgeries and 10,000 intravitreal injections and laser procedures. I am also the co-founder of Aavinyaa Strategies, a healthcare venture studio.

Where does Dr Obuli Ramachandran see retina patients, and how do I book an appointment?

I see retina patients at Centre for Sight hospitals in Delhi NCR, including New Delhi and Gurugram. To book an appointment, call Centre for Sight on 011-42504250.

Which retinal conditions does he treat?

I treat retinal detachment, diabetic retinopathy, diabetic macular oedema, macular hole, epiretinal membrane, vitreous haemorrhage, age-related macular degeneration, retinal vein occlusion, central serous chorioretinopathy, endophthalmitis and eye injuries that involve the retina.

What is a vitrectomy, and when is it needed?

A vitrectomy is an operation in which I remove the vitreous gel from inside the eye through three small openings. It is done for retinal detachment, macular hole, bleeding inside the eye from diabetes, and infection inside the eye.

How urgent is a retinal detachment?

A retinal detachment is an emergency. New flashes of light, a sudden shower of floaters or a dark curtain across part of your vision need a retina examination on the same day. Surgery works best before the centre of the retina detaches.

What are intravitreal injections used for?

I inject anti-VEGF medicines or a steroid implant into the eye to treat diabetic macular oedema, wet age-related macular degeneration and retinal vein occlusion. The procedure takes a few minutes under anaesthetic drops.

How often should a person with diabetes have a retina examination?

A person with diabetes needs a retina examination once a year while the retina is normal, and more often once diabetic retinopathy is found.

What health economics research does he do in ophthalmology?

I study what eye treatments cost and what patients gain from them. My published work includes a study of higher-dose aflibercept that reduced clinic visits by 22.6%. I am building a cost-utility analysis of treatments for diabetic macular oedema in India.

Does he advise eye hospitals, healthcare startups and investors?

Yes. Through Aavinyaa Strategies I advise healthcare startups on clinical validation and regulatory approval, work with clinic and hospital owners on operations and expansion, and carry out clinical and operational due diligence for venture capital, private equity and angel investors. I have evaluated more than 100 healthcare ventures.

What is the Sector Report 2026-27?

It is my study of five years of audited financial statements of twelve Indian eye care chains and hospitals, from FY22 to FY26. It covers market size, government scheme rates, return on capital, valuation multiples and predictions to 2030.

How do I invite Dr Obuli Ramachandran to speak or collaborate?

Write to me at the address in the Contact section. I speak on vitreoretinal surgery, anti-VEGF therapy, health economics in ophthalmology and AI in eye care.

Contact

Enquiries and Appointments

Appointments

Enquiries

Professional enquiries

Advisory roles, health economics and outcomes research, clinical validation, speaking and collaborations.

dr.obuliramachandran@gmail.com

Profiles

ORCID 0000-0001-8498-9538

Publications on Google Scholar

LinkedIn, where I publish my essays

For patients

I see retina patients at Centre for Sight in Delhi NCR. To book an appointment, call Centre for Sight.

011-42504250

Share your experience

If I have treated you, you can write about your experience on the Google page of Centre for Sight, Safdarjung Enclave. Please mention Dr Obuli Ramachandran, so that the hospital knows who treated you.

Write a review on Google

Centre for Sight, Safdarjung Enclave, on Google Maps